Patients with or without HF: 1 trials - GISSI 3
Systematic early treatment (with or without sign of HF): 1 trials - GISSI 3
Patient with history of atrial fibrillation: 1 trials - Van den Burg
Patients without history of AF (primary prevention): 1 trials - GISSI-3 (AF ancillary study)
All type of patients: 1 trials - ALLHAT (lisi vs chlor, diabetic subgroup)
Patients with hypertension: 1 trials - ALLHAT (lisi vs chlor, diabetic subgroup)
Patients with or without hypertension: 1 trials - ALLHAT (lisi vs chlor, diabetic subgroup)
6 trials - ATLAS - Gilbert - Giles - Zwehl - International Study Group (Lewis) - Rucinska-c (lisinopril)
All type of patient: 2 trials - ALLHAT (ACEI vs amlodipine) - ALLHAT (ACEI vs chlorthalidone)
Diabetic patients : 1 trials - ALLHAT (lisi vs chlor, diabetic subgroup)
Patients with additional risk factor: 2 trials - ALLHAT (ACEI vs amlodipine) - ALLHAT (ACEI vs chlorthalidone)